Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge

This is a protocol to screen healthy volunteers for future and ongoing LMIV malaria drug, vaccine, or controlled human malaria infection (CHMI) trials. A complete medical history and blood and urine samples will be obtained for evaluation.

Contact Information

Contact the LMIV Clinical Team  

Email: LMIVClinicalTrial@mail.nih.gov 

Phone: 240-627-3355 

Mosquito Saliva Can Weaken Our Defenses Against Deadly Dengue

Hidden "Super Spreaders" Spur Dengue Fever Transmission

Engineering a Malaria Vaccine

Small Study Shows Promise for Antimalarial Monoclonal Antibody to Prevent Malaria

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.medschool.umaryland.edu/news/2023/Small-Study-Shows-Promise-for-Antimalarial-Monoclonal-Antibody-to-Prevent-Malaria.html
Research Institution
University of Maryland School of Medicine
Short Title
Small Study Shows Promise for Antimalarial Monoclonal Antibody to Prevent Malaria
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African Adults

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.medschool.umaryland.edu/news/2022/A-Three-Dose-Malaria-Vaccine-Shows-Safety-Efficacy-in-West-African-Adults.html
Research Institution
University of Maryland School of Medicine
Short Title
A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African Adults
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

Potential Drug Takes Aim at Emerging Chikungunya Virus

Unusual Type of Antibody Shows Ultrapotent Activity Against Zika

How Human Cells Become Zika Virus Factories

How to Stop the Next Pandemic Before It Starts

Subscribe to Mosquito-Borne Diseases